Susquehanna International Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-54,900
Closed -$1.39M 13585
2025
Q1
$1.39M Sell
54,900
-183,100
-77% -$5.44M ﹤0.01% 6413
2024
Q4
$8.18M Buy
238,000
+39,300
+20% +$1.77M ﹤0.01% 2903
2024
Q3
$9.82M Buy
198,700
+176,000
+775% +$9.02M ﹤0.01% 2636
2024
Q2
$1.37M Buy
22,700
+11,900
+110% +$680K ﹤0.01% 5867
2024
Q1
$557K Sell
10,800
-1,800
-14% -$88.4K ﹤0.01% 8262
2023
Q4
$508K Sell
12,600
-108,700
-90% -$3.19M ﹤0.01% 8628
2023
Q3
$3.38M Buy
+121,300
New +$3.62M ﹤0.01% 4180

Other funds holding RXST

Susquehanna International Group's RXST Position: Q1 2026 in Review

Susquehanna International Group reduced its RxSight (RXST) stake by 14% in Q1 2026, selling an estimated $95.2K and leaving 70,293 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #10023.

Susquehanna International Group first reported a position in RXST in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.57M in Q2 2023. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Susquehanna International Group held 70,293 shares of RxSight worth $433K as of Q1 2026.
  • Susquehanna International Group sold 11,461 RxSight shares in Q1 2026, an estimated $95.2K.
  • RxSight made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10023 holding.
  • Susquehanna International Group first reported a position in RxSight in Q1 2022 and has held it in 14 quarters since.
  • Susquehanna International Group's RxSight position peaked at $1.57M in Q2 2023.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.